Search research articles
Contact Us
Filters
Showing results (381-390 of 392) with videos related to
Page
of 40
Sort By:
Annals of Surgery
|
June 9, 2017
Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy
Brett L Ecker, Matthew T McMillan, Horacio J Asbun, et al.
Annals of Surgery
|
January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX
Ingmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
Acta Neuropathologica
|
August 30, 2019
MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement
S Donkervoort, R Sabouny, P Yun, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
May 21, 2026
Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic models
Ammar A Javed, Mahsoem Ali, Omar Mahmud, et al.
Journal of the National Cancer Institute
|
September 3, 2025
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma
Ammar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.
Cancer Letters
|
October 31, 2020
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017
Ding Ding, Ammar A Javed, Dea Cunningham, et al.
Journal of the National Cancer Institute
|
May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
British Journal of Cancer
|
May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study
Thomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
Annals of Surgery
|
March 5, 2019
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons
Patricia Sánchez-Velázquez, Xavier Muller, Giuseppe Malleo, et al.
JAMA Network Open
|
June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy
Thomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
Page
of 40
Search research articles
Search
Showing results (381-390 of 392) with videos related to
Sort By:
Page
of 40
Annals of Surgery
|
June 9, 2017
Characterization and Optimal Management of High-risk Pancreatic Anastomoses During Pancreatoduodenectomy
Brett L Ecker, Matthew T McMillan, Horacio J Asbun, et al.
Annals of Surgery
|
January 31, 2025
Validation of the PANAMA Score for Survival and Benefit of Adjuvant Therapy in Patients With Resected Pancreatic Cancer after Neoadjuvant FOLFIRINOX
Ingmar F Rompen, Thomas F Stoop, Stijn van Roessel, et al.
Acta Neuropathologica
|
August 30, 2019
MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement
S Donkervoort, R Sabouny, P Yun, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
May 21, 2026
Contemporary challenges in long-term survival prediction in resected pancreatic ductal adenocarcinoma: a transatlantic multicenter development and validation of prognostic models
Ammar A Javed, Mahsoem Ali, Omar Mahmud, et al.
Journal of the National Cancer Institute
|
September 3, 2025
Time-varying impact of established prognostic factors in resected pancreatic ductal adenocarcinoma
Ammar A Javed, Asad Saulat Fatimi, Ingmar F Rompen, et al.
Cancer Letters
|
October 31, 2020
Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017
Ding Ding, Ammar A Javed, Dea Cunningham, et al.
Journal of the National Cancer Institute
|
May 16, 2019
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
Quisette P Janssen, Stefan Buettner, Mustafa Suker, et al.
British Journal of Cancer
|
May 6, 2025
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study
Thomas F Stoop, Y H Andrew Wu, Atsushi Oba, et al.
Annals of Surgery
|
March 5, 2019
Benchmarks in Pancreatic Surgery: A Novel Tool for Unbiased Outcome Comparisons
Patricia Sánchez-Velázquez, Xavier Muller, Giuseppe Malleo, et al.
JAMA Network Open
|
June 18, 2024
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy
Thomas F Stoop, Atsushi Oba, Y H Andrew Wu, et al.
Page
of 40